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Short-term modulation of distal tubule fluid nitric oxide
in vivo by loop NaCl reabsorption
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Short-term modulation of distal tubule fluid nitric oxide in vivo
by loop NaCl reabsorption.
Background. Intrarenal nitric oxide (NO) production and
signaling effects are influenced by NaCl loading. To gain further
insight into NO mechanisms we determined whether rat distal
tubular fluid (DTF) [NO] and collected NO may acutely change
when NaCl loop delivery is altered.
Methods. An NO microelectrode was used to measure real-
time DTF [NO] and DT-collected NO. With proximal flow
blocked (open system), 150 mmol/L NaCl, with and without
10−4 mol/L furosemide was perfused with measurement of loop
[Cl] reabsorption. Using a closed system, DTF [NO] was also
determined using several different loop perfusates.
Results. In the open system, perfusion with 40 nL/min of
150 mmol/L NaCl to which 10−4 mol/L furosemide was added,
DT [NO] and DT-collected NO was approximately twice that
measured with perfusion of 150 mmol/L NaCl alone, while loop
Cl reabsorption decreased by half. In the closed system, per-
fusion at 10 nL/min of 150 mmol/L NaCl + furosemide 10−4
mol/L also induced a significant rise in DTF [NO] and collected
NO. Perfusion of 10−3 mol/L S-methyl-L-thiocitrulline (SMTC)
with 150 mmol/L NaCl, induces a significant drop in DT [NO],
but without a significant increase in collected NO. Furthermore,
with addition of 10−3 mol/L SMTC to the 150 mmol/L NaCl +
10−4 furosemide perfusate, the rise in DT [NO] was prevented.
Analysis of covariance showed that flow changes within, or be-
tween all groups, had no significant additional effect.
Conclusion. In both open and closed loop perfusion systems,
10−4 mol/L furosemide inhibition of NaCl transport stimulates
net loop NO emission independent of flow; 10−3 mol/L SMTC +
150 mmol/L NaCl reduces DT [NO], but not DT-collected NO.
Short-term net NO emission from the entire loop, as collected
in distal tubule fluid, increases with inhibition of loop NaCl
transport.
In the loop of Henle, NO is believed to alter solute
transport and influence the tubuloglomerular feedback
(TGF) response [1–5]. In the isolated rabbit cTAL, with
1Statistical analyses were performed by James Jaffey.
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attached glomerulus, it has been recently reported that
macula densa (MD) cell NO synthesis increases with in-
creased NaCl perfusion [6]. Also, in short-term in vitro
experiments, NO has been shown to be synthesized by
the TAL and inhibits TAL NaCl transport [7]. Moreover,
there is evidence that NO derived from TAL cells may
diffuse to the MD site and further mitigate TGF affer-
ent arteriolar constriction [8]. However, no in vivo data
are available regarding the effects of NaCl loads or trans-
port, on NO synthesis by the entire loop, which includes
the approximately 3 mm TAL segment in the rat [9]. The
TAL segment, comprising perhaps 800 cells[10]—about
20 times the number of MD cells [5]—could be a signif-
icant source of net loop NO emission, unless rapidly de-
graded in tubular fluid, or downregulated by a high NaCl
load.
Accordingly, we reasoned if net loop NO emission is re-
leased in significant quantities, it might also be detected
in distal tubular fluid. Using an NO specific electrode
we recently described [11], real-time distal tubular fluid
[NO] [DTF (NO)] was measured using the classic open
system, where endogenous proximal flow was blocked,
and 150 mmol/L NaCl was perfused at 10 and 40 nL/min,
with and without 10−4 mol/L furosemide. With similar
changes in DT flow, with 40 nL/min perfusion of 150
mmol/L NaCl to which furosemide 10−4 mol/L was added,
DT [NO] and net NO emission was approximately twice
that measured with perfusion of 150 mmol/L NaCl alone,
while loop Cl reabsorption decreased by half. In closed
loop perfusions, 150 mmol/L NaCl was perfused at 10
nL/min, added to the endogenous flow with and with-
out 10−4 mol/L furosemide. The 10−4 mol/L furosemide
perfusate resulted in significantly higher DTF [NO] and
collected NO with a similar modest increase in DT flows.
The results indicate that short-term net NO emission
from the entire loop, as collected in distal tubule fluid,
increases with inhibition of loop NaCl transport.
METHODS
Adult male Sprague-Dawley rats from Charles River,
Canada (St. Constant, Quebec, Canada) weighing
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Fig. 1. Modified World Precision Instruments (WPI) integrated am-
perometric nitric oxide (NO)- sensing electrode. The basic features of
the electrode structure are shown, as previously described [11]. See also
Methods. Reproduced with permission.
between 250 and 350 g were fed a standard laboratory rat
chow (diet 5012; Ralston Purina of Canada, Woodstock,
Ontario, Canada) and had free access to tap water. An-
imals were anesthetized with 100 mg/kg thiobutabarbi-
tal sodium (Inactin; Research Biochemical International,
Natick, MA, USA) and prepared for microperfusion, as
described previously [12].
Our [NO] measurement technique has also been pre-
viously described [11], and is briefly reviewed here. The
structure of the electrode, shown in Figure 1, is a spe-
cially modified [World Precision Instruments (WPI P/N
ISO-NOP007)] design for our in vivo use. Glass insula-
tion is used to preclude NO reactivity outside the tubule;
the reactive membrane length is ∼5–15 lm, and the tip
diameter usually about 5–7 lm. We monitor electrodes
for NO specificity by testing against nitrite and ascor-
bic acid. After calibration in vitro, using a S-nitroso-
N-acetylpenicillamine (SNAP)-copper sulfate solution, a
zero point is needed between repeated punctures. We
have chosen to use saline on the surface of the rat kidney
to be that point. Thus, after an “extratubular” zero is de-
termined, the puncture is made along the “prepuncture”
track, and the picoamperes (pA) response is taken from
that “zero.” We have also considered the possibility that
NO leaking from the tubule may influence the zero point,
but we have determined that is not a significant concern;
samples of surface fluid were pipetted into the copper sul-
fate solution without any significant response, even after
many tubular segments were punctured. We presumed
that if the pA signal was solely due to intratubular NO, the
signal should be abolished by placing a high-flow saline
perfusion pipette close to the sensing electrode. Indeed,
40 nL/min saline diminished the pA current in a repeated
and reproducible fashion (Fig. 2) to values similar to that
obtained from surface fluid. Assuming that the aqueous
intratubular milieu is not materially different from the in
vitro calibration conditions, the electrode should respond
in an expected manner, within the tiny tubule, when dif-
ferent concentrations of NO were perfused upstream, us-
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Fig. 2. Intratubular NO measurements from a single proximal tubule
with perfusion of saline and/or saline equilibrated with NO. Perfusion
of 40 nL/min saline close to the electrode tip reduced the pA current
to values similar to that obtained from surface fluid. Maintaining a con-
stant 40 nL/min flow, stepwise increments of the saline + NO and NO-
free saline solutions resulted in expected [NO] changes [11]. See also
Methods. Reproduced with permission.
ing two perfusion solutions (with and without NO) with
separate flows ranging from zero to 40 nL/min, with the
total delivery always 40 nL/min. In fact, at constant 40 nL/
min flow, we showed first an intratubular zero point, and
then appropriate step-wise increment and decrement of
responses when an NO containing saline solution was
mixed with an NO free solution, without altering flow,
as shown in Figure 2. Finally, Figure 3 shows an actual
recording—with compressed time axis—from Group 2,
as described below.
Experimental groups
The following solutions were perfused through the
loop, after blockade of endogenous proximal flow (open
system): Group 1 (5 rats, 6 tubules), 150 mmol/L NaCl
perfused at 10 and 40 nL/min with quantitative collections
for flow, and analysis of Cl concentrations, so that col-
lected NO amounts could be calculated, as well as abso-
lute net Cl reabsorption, JCl.. Group 2 (6 rats, 10 tubules),
as for Group 1, with 10−4 mol/L furosemide added to the
150 mmol/L NaCl perfusate.
In 6 additional groups of normal rats, loops of Henle
were perfused with different solutions from the late prox-
imal site at 10 nL/min, without blocking normal flow
(closed system), not disrupting proximal tubule function
[13], and attempting to minimally alter loop flow; Group
3 (5 rats, 10 tubules), 150 mmol/L NaCl; Group 4 (6 rats,
7 tubules), 150 mmol/L NaCl + 10−4 mol/L furosemide;
Group 5 (5 rats, 8 tubules), 150 mmol/L NaCl + 10−3
mol/L SMTC.
In two additional groups, to permit evaluation of higher
NaCl reabsorption and higher flows also in the closed sys-
tem, perfusions were undertaken with 450 mmol/L NaCl,
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Fig. 3. Intratubular real-time NO recordings from Group 2. Responses, pA and nmol/L during loop perfusion of two tubules from Group 2,
with perfusion of 150 mmol/L NaCl + 10−4 mol/L furosemide at 10 and 40 nL/min. Reading from left to right, DT [NO] is determined between
SNAP-copper sulfate calibrations.
Group 6 (4 rats, 10 tubules), and 900 mmol/L mannitol,
Group 7 (4 rats, 7 tubules). Finally, in Group 8 (5 rats,
8 tubules), the effects of combined furosemide and SMTC
added to 150 mmol/L NaCl were measured.
In these studies, the direct measurement of [NO] in real
time requires a separate puncture into a saline superfused
kidney surface; oil impedes the NO electrode sensitivity
and saline is also needed for a “zero” point. Thus, in con-
trast to the usual micropuncture procedure, where tubu-
lar fluid is quantitatively collected for volume flows and
chloride analyses, separate punctures of the same distal
tubule were needed, with oil on the kidney surface. This
approach was taken with Groups 1, 2, 6, 7, and 8, while
the other volume collections were made under identical
experimental conditions, in different tubules, in separate
oil superfused kidneys, but without DT [NO] measured.
Statistical analyses
Paired and unpaired t testing was carried out in all
groups as appropriate (see Results and Tables 1 and 2).
However, to examine the possible independent effect of
flows, both within and between groups, an analysis of co-
variance (ANCOVA) was carried out using individual
flow data from individual tubules, along with the group
effects. The SAS (SAS Institute, Cary, NC, USA) pro-
cedure general linear model (GLM) was used for this
analysis. Finally, for Groups 1 and 2, Pearson correlation
coefficients were determined for several paired variables:
DT [NO], DT-collected NO, DT [Cl], DT Cl delivery,
and JCl.
RESULTS
Figure 4 and Table 1 show results from Groups 1 and
2, where at both 10 and 40 nL/min perfusion, furosemide
inhibition significantly increased DT-collected NO, while
JCl is significantly reduced. The DT [NO] at 40 nL/min is
also significantly higher with furosemide inhibition, but
does not quite reach significance at 10 nL/min. Indeed,
the effects of furosemide, as well as flows, and JCl very
closely approximate the data of Wright et al [14] obtained
30 years ago. When single-tubule values were pooled
from Groups 1 and 2, to which 20 nL/min additional
perfusion data were added (not reported elsewhere, see
above) the DT-collected NO was highly correlated with
DT Cl delivery, P < 0.0001.
Table 2 shows data from Groups 3–5. In Groups 3
and 4, DT-collected NO is significantly higher, P < 0.05
or less, compared to free-flow control during closed
perfusion with 150 mmol/L NaCl or with furosemide
addition. Importantly, the increase in collected NO with
furosemide addition (Group 4) is associated with a sig-
nificant increase in DT [NO] versus Group 4 control,
P < 0.05, despite a significant increase in DT flow. With
further addition of 10−3 mol/L SMTC to the furosemide/
Levine et al: Loop NaCl transport and distal tubule fluid NO 187
Table 1. Perfusion of 10 and 40 nL/min of 150 mmol/L NaCl with and without 10−4 mol/L furosemide
Perfusion solution
Group 1 150 mmol/L NaCl Group 2 150 mmol/L NaCl + 10−4 mol/L furosemide
Rats/tubules 5/6 6/10
Perfusion rate nL/min 10 40 10 40
Flow nL/min 5.2 ± 0.8 25.4 ± 2.5a 6.4 ± 0.5 29.2 ± 2.5b
[NO] nmol/L 161 ± 33 116 ± 25 219 ± 28 214 ± 32c
Collected NO fmol·min−1 778 ± 119 2749 ± 549a 1364 ± 249 6073 ± 940b,c
[Cl] mmol/L 51 ± 5 135 ± 6a 159 ± 7d 166 ± 4c
JCl pmol·min−1 1277 ± 36 2673 ± 335a 480 ± 71d 1321 ± 429b,c
Values are mean ± SEM.
aP < 0.05 vs. 10 nL/min (Group 1), by paired t test.
bP < 0.05 vs. 10 nL/min (Group 2), by paired t test.
cP < 0.05 vs. 40 nL/min (Group 1), by unpaired t test.
dP < 0.05 vs. 10 nL/min (Group 1), by unpaired t test.
Table 2. Perfusion at 10 nL/min added to endogenous late proximal fluid
Group Perfusion solution Rats/tubules DT V nL/min DT [NO] nmol/L Collected NO fmol·min−1
3 150 mmol/L NaCl Control 5/10 7.5 ± 1.0 198 ± 16 1484 ± 120
Perfusion 5/10 12.1 ± 2.7 196 ± 28 2369 ± 334a
4 150 mmol/L NaCl Control 6/7 7.5 ± 0.8 169 ± 26 1266 ± 197
+ 10−4 mol/L furosemide Perfusion 6/7 12.8 ± 1.1a 245 ± 31a 3136 ± 395a,b
5 150 mmol/L NaCl Control 5/10 5.5 ± 1.3 117 ± 14 644 ± 77
+ 10−3 mol/L SMTC Perfusion 5/10 11.3 ± 1.9a 78 ± 11a 884 ± 126
Values are mean ± SEM.
aP < 0.05 vs. control, by paired t test.
bP < 0.05 vs. Group 3, control, by unpaired t test.
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Fig. 4. Distal tubule fluid [NO] and col-
lected NO during 10 and 40 nL/min loop
perfusions (open system). Results shown are
with 150 mmol/L NaCl (closed circles) or
150 mmol/L NaCl + 10−4 mol/L furosemide
(open squares). During furosemide inhibition
DTF [NO] is significantly higher at 40 nL/min.
Left panel, ∗P < 0.05. Collected NO with
furosemide inhibition (40 nL/min perfusion)
is significantly (∗∗P < 0.01) higher than the
10 nL/min perfusions from both groups, and
is also significantly different (P < 0.05) than
the 40 nL/min Group 1 response. See also
Table 1 and Results.
150 mmol/L NaCl solution (Group 8, not shown else-
where), the rise in DT[NO] was prevented: 175 ± 23 ver-
sus 180 ± 23 nmol/L. Table 2 and Figure 5 also show that
in Group 5, addition of 10−3 mol/L SMTC to 150 mmol/L
NaCl induces a significant drop in DT [NO], but without
a significant increase in collected NO.
In Group 6, 450 mmol/L NaCl perfusion, DT [NO] dur-
ing the control period was 142 ± 26 nmol/L, which was
significantly reduced to 85 ± 22 nmol/L during perfusion,
P < 0.01 by paired t testing. In Group 7 (900 mmol/L
mannitol) the mean DT [NO] perfusion value of 138 ±
37 nmol/L was higher than the control period value of
109 ± 22 nmol/L, but did not reach statistical signif-
icance. In contrast, DT-collected NO values increased
significantly for Group 6 during control and perfusion
periods: 694 ± 129 versus 1688 ± 445 fmol·min−1, P <
0.02. Corresponding Group 7 values were 697 ± 164 and
3769 ± 1073 fmol·min−1, with both perfusion values sig-
nificantly different from controls, P < 0.01. Mannitol per-
fusion in Group 7 was also associated with a fourfold
increase in flow, 6.8 ± 1.2 vs. 28.5 ± 3.1 nL/min, with
the perfusion flow rate being ∼10 nL higher than that
measured in Group 6, but nevertheless, the DT [NO] did
not decrease. Measurement of DT [Cl] in both Groups 6
and 7 permitted rough estimates of chloride reabsorption
(late proximal Cl entry continues in these closed perfu-
sions) and indicate, as expected, NaCl reabsorption is en-
hanced with 450 NaCl, and is precipitously reduced with
900 mmol/L mannitol.
Analysis of possible flow effects
As noted in Methods, flow effects on [NO] and DT-
collected NO were examined by ANCOVA in all sin-
gle tubules both within and between groups. Thus, even
though mean flows in Groups 1 and 2 were almost iden-
tical (open system) at 10 and 40 nL/min, there was no
significant within group effect, even with the addition
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Fig. 5. Distal tubule fluid [NO] during 10 nL/min loop perfusion
(closed system) in Groups 3–5. Group 3, 150 mmol/L NaCl (closed
circles); Group 4, 150 mmol/L NaCl + 10−4 mol/L furosemide (open
squares); Group 5 (closed squares) 150 mmol/L NaCl + 10−3 mol/L
SMTC. ∗P < 0.05 by paired t testing of perfusion vs. control values for
individual tubules. See also Table 2 and Results.
of tubules perfused at 20 nL/min, not shown elsewhere
in this report. Similarly, in the closed perfusion studies,
with Group 3 (150 mmol/L NaCl), Group 4 (150 mmol/L
NaCl +10−4 mol/L furosemide), and Group 5 (150 NaCl
mmol/L+ 10−3 mol/L SMTC), no significant flow effects
were present. All significant changes in [NO] and col-
lected NO are attributable to the perfusate used. Most
important, even with Group 6 (450 NaCl mmol/L), and
Group 7 (900 mmol/L mannitol), despite an approxi-
mately 10 nL/min increase in flow, analysis of within
group and between group, single-tubule responses clearly
reveal that flow, per se, did not significantly influence NO
responses independent of the perfusate intervention. Al-
though it might be expected that in Groups 3–5 there are
no significant flow effects, where flow does not increase
by more than about 5 nL/min, it might seem more likely
that high flows would have an effect. But even though
900 mmol/L mannitol perfusion may have delivered more
NO to the DT site by convective flow, this effect was not
significant. In short, no significant changes in DT [NO]
and collected rates of NO are attributable to changes in
flow; rather, the significant changes result from the com-
position of the perfusates used (Group effects).
DISCUSSION
In the present studies we directly measured nitric oxide
concentrations [NO] in distal tubular fluid (DTF) during
perfusion of solutions that altered loop NaCl reabsorp-
tion. We hypothesized that with the use of real-time NO
specific electrodes, DTF [NO] should change percepti-
bly if loop net NO emission is altered by a substantial
portion of epithelial cells making up the entire loop, or,
if very few cells were involved, the local changes in NO
emission would have to be profound.
Using the classic open loop perfusion system [14],
which prevents both proximal tubular fluid NaCl and
NO from entering the loop, we perfused 150 mmol/L
NaCl with and without 10−4 mol/L furosemide; at
both 10 and 40 nL/min perfusion, with DT flow un-
changed, furosemide inhibition significantly increased
DT-collected NO, while significantly suppressing JCl. Us-
ing the closed loop perfusion system, considered by some
to be more physiologic because endogenous flow is intact
and has provided unexpected TGF responses at low flows
[13], we perfused the loop with 150 mmol/L NaCl, and
evaluated the effects of 10−4 mol/L furosemide. Again,
furosemide elicited significant increases in both DT [NO]
and DT-collected NO, with the identical modest increase
in DT flow. Although perfusion of the specific nNOS in-
hibitor SMTC reduced DT [NO] when compared to free-
flow controls, and prevented the furosemide-induced rise
in DT [NO], it did not reduce the collected NO at the DT
site. To assess higher NaCl reabsorption and higher flow
rates, perfusions were undertaken with 450 mmol/L NaCl
and 900 mmol/L mannitol. Similar to the furosemide ef-
fect, mannitol elicited a fivefold increase in collected NO.
Finally, in all protocols we examined between and
within group flow effects. ANCOVA of all individual
tubules within and between groups indicates the signifi-
cant changes in DT [NO] and collected rates of NO are
attributable not to changes in flow, but rather to the com-
position of the perfusates used.
How far along the nephron may changes in tubular
fluid [NO] be detected?
It is clear that along the nephron, as flow varies and wa-
ter is abstracted, tubular fluid NO concentrations must be
the result of a dynamic equilibration process whereby NO
freely diffuses into the lumen from the interstitial sink of
NO, as well as being influenced by multidirectional dif-
fusion of NO from those apical cells which generate NO.
Changes in DTF [NO] as a result of loop effects might be
readily detectable if NO is stable in tubular fluid over 1
to 3 minutes, and if the change in net NO entry into the
loop tubular fluid is brisk—for example, if the approxi-
mate 800 cells [10] of the cortical TAL added nitric oxide
gas to the tubule fluid. Assuming that tubular fluid, free
of heme, corresponds to a simple aqueous solution, it has
been calculated that nmol/L NO concentrations have an
unexpectedly long half-life—from 100 to 500 seconds [15,
16]. Using an NO electrode design similar to ours (from
the same manufacturer), Hakim et al [17] showed that a
1200 nmol/L NO concentration in aqueous solution with
a pO2 of 40 mm Hg, has a half-life of 7 minutes. Moreover,
very recent studies involving direct measurement and in-
fusion of NO equilibrated saline into the human brachial
artery show, remarkably, that intact NO can travel sig-
nificant distances along the vascular bed [18]. Therefore,
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based on these considerations, we believe there is no ev-
idence to dismiss the possibility that alterations in net
emission rates of NO from the entire loop may elicit 50
to 200 nmol/L NO concentration changes in distal tubule
fluid.
Interpretation of results
We stress the following comments are speculative—we
have provided no measurements of any aspects of cellu-
lar NO emission by loop segments or the TGF response.
It is clear that 10−4 mol/L furosemide, when perfused
with isotonic NaCl at high flow in the open system, or at
10 nL/min in the closed system, results in significant in-
creases in both DT [NO] and collected NO, either when
flows are unchanged (Group 1), or with modest increases
in flow (Group 4). Thus, reduced NaCl loop transport,
as indicated by these observations alone, is associated
with increased DT [NO] and net NO emission from the
entire loop. In the open system, the observation that
the increase in DT [NO] is not significant at 10 nL/min
150 mmol/L NaCl perfusion is perhaps consistent with
past observations (using the closed system), that at low
flow, NOS inhibitors have minimal or no effect on the
TGF response [13].
It is not clear that the significant fall in DT [NO] as-
sociated with SMTC perfusion, or its effect to prevent
the furosemide-induced increase in DT [NO] (Group 8),
necessarily conflicts with the report of Liu et al, showing
that the NO-sensitive fluorophore 4,5-diaminofluorescin
(DAF-2) detected increased MD intracellular NO forma-
tion when NaCl delivery is acutely increased [6]. It is also
uncertain that MD cell NO content need necessarily par-
allel DT NO measurements 3 to 500 lm downstream [5].
In fact, NO collected at the DT site, likely a reflection of
net loop NO emission, is not increased with SMTC perfu-
sion. Although it is very likely NO concentration changes
are important at local signaling/transport sites, our data
do not suggest that net loop NO synthesis or emission
are changed by SMTC. In any case, we may speculate
that with high NaCl loads, it is still possible for the MD
cells to increase NO synthesis, while a much greater NO
emission into tubular fluid, from the entire loop, may fall.
We note that TAL cells, likely 20 times the number of MD
cells [10], also synthesize significant quantities of eNOS-
derived NO to diffuse to the MD site [6]. Indeed, it is
possible that this TAL NO emission may be downreg-
ulated by high NaCl delivery, but there are no data yet
available to support this conjecture.
A final speculation is derived from the view that NO
likely inhibits collecting duct sodium transport [19]. The
demonstration of higher rates of NO entry into the distal
nephron under conditions of decreased loop NaCl trans-
port might be considered to act as “feed-forward” signal,
which would support continued reduction of downstream
NaCl transport.
CONCLUSION
Our results indicate that short-term net NO emission
from the entire loop, as collected in distal tubule fluid,
increases with inhibition of loop NaCl transport.
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